Key Record Dates
ClinicalTrials.gov Identifier: | NCT04605094 |
---|---|
Brief Title: | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis |
First Submitted : | September 1, 2020 |
First Submitted that Met QC Criteria : | October 21, 2020 |
First Posted : | October 27, 2020 |
Last Update Submitted that Met QC Criteria : | January 4, 2023 |
Last Update Posted : | January 5, 2023 |